USA News
Adapting to Progress: Evolving nAMD Trials Amid Therapeutic Expansion
Adapting to Progress: Evolving nAMD Trials Amid Therapeutic Expansion
From The Eye Health Academy
Drs. Dilsher Dhoot and Arshad M. Khanani explain the key aspects of the recently released FDA guidelines for clinical trial design in neovascular age-related macular degeneration and how these changes will influence the interpretation of clinical trial data and the subsequent integration of these therapies into clinical practice.
